Nur Masyithah Zamruddin
Laboratorium Penelitian dan Pengembangan Kefarmasian “Farmaka Tropis”, Fakultas Farmasi, Universitas Mulawarman, Samarinda, Indonesia

Published : 2 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 2 Documents
Search

Identifikasi Drug Related Problems Pada Pasien Congestive Heart Failure di Rumah Sakit “X” Balikpapan: Identification of Drug-Related Problems in Patients with Congestive Heart Failure at “X” Hospital Balikpapan Esa Wi Fatma; Nur Masyithah Zamruddin; Adam M. Ramadhan
Proceeding of Mulawarman Pharmaceuticals Conferences Vol. 14 (2021): Proceeding of Mulawarman Pharmaceuticals Conferences
Publisher : Fakultas Farmasi, Universitas Mulawarman, Samarinda, Indonesia

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (314.807 KB) | DOI: 10.25026/mpc.v14i1.554

Abstract

Heart failure is a condition where the heart fails to pump blood to meet the needs of the tissues. CHF patients are generally given at least 4 types of drugs, namely ACEIs, beta blockers, diuretics and digoxin. As a result, if it is not considered properly, it will be detrimental to the patient. This study is a non-experimental observational study with retrospective data collection on medical record data of patients who meet the inclusion criteria with the aim of knowing patient characteristics, knowing the description of drug use and knowing the incidence of DRPs in CHF patients at Hospital "X" Balikpapan. The results obtained from 106 patients, male patients were taller than female by 68 patients (64.15%), the highest age was in the late elderly category (56-65 years) as many as 40 patients (37.73%), the highest comorbid namely HHD 31 patients (29.24%), VES 16 patients (15.10%), renal insufficiency 13 patients (12.26%) and hypokalemia 13 patients (12.26%). The description of drug use in CHF patients included aspirin in 77 patients (72.64%), furosemide 62 patients (58.49%) and bisoprolol 49 patients (46.22%). The incidence of DRPs in the drug interaction category was 88 patients (83.01%), indicated without drugs 10 patients (9.43%), drugs without indications 4 patients (3.77%), inaccuracy of drug selection 2 patients (1.88%) , and failure to receive medication in 1 patient (0.94%), no incidence was found in the low dose, over dose and ADR categories.
Potensi Seduhan Daun Pepaya (Carica papaya L.) Kombinasi Madu Terhadap Intensitas Nyeri Haid (Dysmenorrhea) pada Wanita: Potential Infusion of Papaya Leaves (Carica papaya L.) combined with honey Against the Intensity Menstrual Pain (Dysmenorrhea) in Women Pakendek Fefryani; Nur Masyithah Zamruddin; Niken Indriyanti
Proceeding of Mulawarman Pharmaceuticals Conferences Vol. 14 (2021): Proceeding of Mulawarman Pharmaceuticals Conferences
Publisher : Fakultas Farmasi, Universitas Mulawarman, Samarinda, Indonesia

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (319.644 KB) | DOI: 10.25026/mpc.v14i1.578

Abstract

Menstruation is a sign that a teenager has entered puberty. Menstruation can cause pain or cramping called dysmenorrhea. In this study, 1 papaya leaf (Carica papaya L.) was used combined with 30 ml of honey. The purpose of this study was to determine the effectiveness of steeping papaya leaves (Carica papaya L.) combined with honey on the intensity of menstrual pain in women. In this test, 2 groups were used, namely the positive test and control using the Quasi Experimental research method by looking at the potential of herbal preparations on the NRS (Numerical Rating Scale) scale sheet given before and after treatment. Based on the results of the study, it was found that the effectiveness of papaya leaf tea with a combination of honey before and after administration to reduce the intensity of pain felt in each subject was significant, namely 0.000 (p <0.05) from the two treatment groups, namely the test and positive control, the comparison of pain was obtained from the leaves. papaya combined with honey was better and more effective in reducing dysmenorrhea pain after NSAIDs with a test mean ratio of 11.70 and positive control 9.30.